KR20240008846A - 인지 기능을 개선하기 위한 조성물 - Google Patents

인지 기능을 개선하기 위한 조성물 Download PDF

Info

Publication number
KR20240008846A
KR20240008846A KR1020237038452A KR20237038452A KR20240008846A KR 20240008846 A KR20240008846 A KR 20240008846A KR 1020237038452 A KR1020237038452 A KR 1020237038452A KR 20237038452 A KR20237038452 A KR 20237038452A KR 20240008846 A KR20240008846 A KR 20240008846A
Authority
KR
South Korea
Prior art keywords
composition
test
mental
dha
cognitive function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237038452A
Other languages
English (en)
Korean (ko)
Inventor
마사타카 가와라사키
마사키 반도우
가츠야 기시카와
Original Assignee
오노 야꾸힝 고교 가부시키가이샤
마루하 니치로 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오노 야꾸힝 고교 가부시키가이샤, 마루하 니치로 가부시키가이샤 filed Critical 오노 야꾸힝 고교 가부시키가이샤
Publication of KR20240008846A publication Critical patent/KR20240008846A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/184—Emulsifier
    • A23V2250/1842—Lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/204—Animal extracts
    • A23V2250/2042—Marine animal, fish extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020237038452A 2021-05-17 2022-05-16 인지 기능을 개선하기 위한 조성물 Pending KR20240008846A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2021-082910 2021-05-17
JP2021082910 2021-05-17
PCT/JP2022/020368 WO2022244727A1 (ja) 2021-05-17 2022-05-16 認知機能を改善するための組成物

Publications (1)

Publication Number Publication Date
KR20240008846A true KR20240008846A (ko) 2024-01-19

Family

ID=84140489

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237038452A Pending KR20240008846A (ko) 2021-05-17 2022-05-16 인지 기능을 개선하기 위한 조성물

Country Status (5)

Country Link
JP (1) JPWO2022244727A1 (https=)
KR (1) KR20240008846A (https=)
CN (1) CN117337186A (https=)
TW (1) TW202313075A (https=)
WO (1) WO2022244727A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2808406T3 (es) * 2007-06-26 2021-02-26 Nutricia Nv Mejora de la memoria en sujetos con un mini examen del estado mental de 24-26
JP2010053054A (ja) * 2008-08-27 2010-03-11 Nof Corp 睡眠の改善方法
WO2013066151A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Improving recognition
GB201405033D0 (en) * 2014-03-20 2014-05-07 Isis Innovation Combination therapy
JP6242746B2 (ja) * 2014-05-26 2017-12-06 キリン株式会社 記憶学習機能を向上する医薬、食品、組成物
GB201720119D0 (en) * 2017-12-04 2018-01-17 Howard Foundation Holdings Ltd Prevention and/or treatment of neurodegenerative disease
WO2021132516A1 (ja) * 2019-12-26 2021-07-01 マルハニチロ株式会社 多価不飽和脂肪酸が結合したリン脂質を含む魚卵脂質組成物

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
H Tokuda, et al., Low Doses of Long-chain Polyunsaturated Fatty Acids Affect Cognitive Function in Elderly Japanese Men : A Randomized Controlled Trial. Journal of Oleo Science 2015 ; 64 : 633-44.
N Sinn, et al., Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment : a 6-month randomised controlled trial. British Journal of Nutrition 2012 Jun ; 107 : 1682-93.
Robert P Friedland. Fish consumption and the risk of Alzheimer disease : is it time to make dietary recommendations? Archives of Neurology 2003 ; 60 : 923-4.
오오쿠보 타케시 등 : PC-DHA (DHA 결합형 포스파티딜콜린) 는 REM 수면량에 영향을 미친다-식 (食) 환경이 수면에 주는 영향-, 일본 수면 환경 학회 잡지, 8, 9-14 (2011)
이케다 이쿠오. 식품 기능성 지질의 기초와 응용. CMC 출판 ; 2018. p.119-123.

Also Published As

Publication number Publication date
JPWO2022244727A1 (https=) 2022-11-24
CN117337186A (zh) 2024-01-02
WO2022244727A1 (ja) 2022-11-24
TW202313075A (zh) 2023-04-01

Similar Documents

Publication Publication Date Title
Berge et al. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels
Fassett et al. Astaxanthin in cardiovascular health and disease
US11135230B2 (en) Lipid compositions with high DHA content
Noce et al. Usefulness of extra virgin olive oil minor polar compounds in the management of chronic kidney disease patients
van de Rest et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial
Lane et al. The bioavailability of an omega-3-rich algal oil is improved by nanoemulsion technology using yogurt as a food vehicle
Girodon et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial
Merchant et al. Nutritional supplementation with Chlorella pyrenoidosa lowers serum methylmalonic acid in vegans and vegetarians with a suspected vitamin B12 deficiency
Duncan et al. Vitamin E nicotinate
Nicolson Membrane Lipid Replacement: clinical studies using a natural medicine approach to restoring membrane function and improving health
JP7368085B2 (ja) アスタキサンチンを含有する飲食品組成物
US20100056484A1 (en) Dietary supplemental composition effective for enhancing cognitive performance, elevating mood and reducing oxidative stress
López-Plaza et al. Effect of Regular Consumption of a Miraculin-Based Food Supplement on Taste Perception and Nutritional Status in Malnourished Cancer Patients: A Triple-Blind, Randomized, Placebo-Controlled Clinical Trial-CLINMIR Pilot Protocol
Tenore et al. Plasma lipid lowering effect by a novel chia seed based nutraceutical formulation
Tomar et al. An overview of regulation for nutraceuticals and concept of personalized nutraceuticals
KR20230164033A (ko) 수면의 질을 개선하기 위한 조성물
Tobin et al. Effect of cooking and in vitro digestion on the stability of co-enzyme Q10 in processed meat products
Al-Khamees et al. Status epilepticus associated with borage oil ingestion
Miller et al. Bioavailability of orally administered active lipid compounds from four different greenshell™ mussel formats
Dimitrova et al. Intravenous lipid emulsions in anticonvulsants’ toxicity
Abraham The history of iodine in medicine part I: from discovery to essentiality
KR20240008846A (ko) 인지 기능을 개선하기 위한 조성물
TW202430197A (zh) 用於增加精子數及/或精子濃度之組合物
Sugimoto et al. Effects of daily consumption of scallop oil prepared from internal organs of Japanese giant scallop (Patinopecten yessoensis) on serum lipid composition and its safety: A randomized, double-blind, placebo-controlled, parallel group comparison study
Kolahi et al. The evaluation of concurrent supplementation with vitamin E and omega-3 fatty acids on plasma lipid per oxidation and antioxidant levels in patients with rheumatoid arthritis

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20231107

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250513

Comment text: Request for Examination of Application